| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9391672 | Journal of Vascular and Interventional Radiology | 2005 | 9 Pages |
Abstract
The risk of liver toxicities in patients with unresectable HCC treated with TheraSpheres increases with increasing pretreatment total bilirubin level and liver radiation dose to a maximum of 150 Gy for a single administration. The toxicities attributed to treatment resolved over time, and none of the patients studied had confirmed radiation-induced liver disease. Consequently, doses as high as 150 Gy on a single administration and as high as 268 Gy on repeated administrations were well tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
James E. PhD, Riad MD, MBA, Brian I. MD, PhD, Janet E. MD, Michael C. MD, Jean Francois H. MD, Kathleen MS, Mark MS, Kenneth MA,